Clinical trial reportEuropean journal of haematologyPublished
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient-Reported Outcomes
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- Counties
- Mercer County, Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- European journal of haematology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Treatment Outcome; Quality of Life; Aged; Aged, 80 and over; Middle Aged; Female; Male
- PubMed ID
- 39952901
- PubMed Central ID
- PMC11976685
- Open access
- Yes, open
- Added to directory
- Source checked